Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR3 | P51677 | 2/20 | 0.37 |
| ▸ | ROCK2 | O75116 | 7/20 | 0.36 |
| ▸ | ROCK1 | Q13464 | 6/20 | 0.36 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 4/20 | 0.34 |
| ▸ | AURKA | O14965 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25531283 | 0.90 | CACNA1H (0.36) | ROCK2ROCK1MAP4K4AURKA | |
| SCHEMBL25528475 | 0.90 | CACNA1H (0.36) | ROCK2ROCK1MAP4K4AURKA | |
| SCHEMBL25530204 | 0.86 | ROCK1 (0.35) | CCR3ROCK2ROCK1 | |
| SCHEMBL25528470 | 0.86 | AURKA (0.37) | ROCK2ROCK1MAP4K4AURKA | |
| SCHEMBL25528473 | 0.83 | AURKA (0.35) | ROCK2ROCK1BRD4AURKA | |
| SCHEMBL25528948 | 0.81 | ROCK2 (0.33) | ROCK2ROCK1AURKA | |
| SCHEMBL25528945 | 0.81 | CACNA1H (0.36) | ROCK2ROCK1AURKA | |
| SCHEMBL25531296 | 0.81 | ROCK2 (0.33) | ROCK2ROCK1AURKA | |
| SCHEMBL25531302 | 0.78 | ROCK2 (0.41) | ROCK2ROCK1BRD4 | |
| SCHEMBL25529501 | 0.77 | ROCK1 (0.47) | ROCK2ROCK1BRD4KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023093787-A1 | BENZODIAZEPINE COMPOUND AND APPLICATION THEREOF AS RHO KINASE INHIBITOR | 成都奥睿药业有限公司 | 2023-06-01 | — | — | WO | disclosed |